Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Invion ( (AU:IVX) ).
Invion Limited announced an update to its previous securities issuance, adjusting capacity calculations to utilize 6,641,068 shares from section 7.1A and 394,379 from section 7.1. This update reflects the company’s strategic financial maneuvering to optimize its market position and potentially enhance shareholder value.
More about Invion
Invion Limited operates in the biotechnology sector, focusing on the development and commercialization of innovative medical therapies. The company is primarily involved in creating solutions for the treatment of chronic inflammatory diseases.
Average Trading Volume: 110
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.97M
For detailed information about IVX stock, go to TipRanks’ Stock Analysis page.